CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...
Salisbury, North Carolina, United States and 64 other locations
The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic...
Gastonia, North Carolina, United States and 8 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
Hickory, North Carolina, United States and 49 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Charlotte, North Carolina, United States of America and 175 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Charlotte, North Carolina, United States and 652 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Statesville, North Carolina, United States and 92 other locations
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...
Phase 3
Charlotte, North Carolina, United States and 60 other locations
This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines use...
Phase 4
Charlotte, North Carolina, United States and 23 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes...
Phase 3
Monroe, North Carolina, United States of America and 91 other locations
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes...
Phase 3
Statesville, North Carolina, United States and 133 other locations
Clinical trials
Research sites
Resources
Legal